Header Logo

Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial.

Beisaw NE, Comerota AJ, Groth HE, Merli GJ, Weitz HH, Zimmerman RC, Diserio FJ, Sasahara AA. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial. J Bone Joint Surg Am. 1988 Jan; 70(1):2-10.

View in: PubMed